These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10125324)

  • 1. Productivity and quality assessment associated with conversion from i.v. to oral ranitidine.
    Baciewicz AM; Cowan RI
    Hosp Formul; 1993 Apr; 28(4):397-8. PubMed ID: 10125324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of concurrent monitoring and a preprinted note to modify prescribing of i.v. cimetidine and ranitidine in a teaching hospital.
    Dannenhoffer MA; Slaughter RL; Hunt SN
    Am J Hosp Pharm; 1989 Aug; 46(8):1570-5. PubMed ID: 2773962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Audit of ranitidine administration in parenteral nutrient solutions.
    Hershey AG; Rosen GH; Foster MD; Johnson DS; Martir-Herrero ML; Krieger J; Oh SM
    Am J Hosp Pharm; 1991 Jan; 48(1):104-7. PubMed ID: 1900386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients.
    Fischer MA; Solomon DH; Teich JM; Avorn J
    Arch Intern Med; 2003 Nov; 163(21):2585-9. PubMed ID: 14638558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist intervention program focused on i.v. ranitidine therapy.
    Santora J; Kitrenos JG; Green ER
    Am J Hosp Pharm; 1990 Jun; 47(6):1346-9. PubMed ID: 2368729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computerized surveillance of adverse drug events in hospital patients. 1991.
    Classen DC; Pestotnik SL; Evans RS; Burke JP
    Qual Saf Health Care; 2005 Jun; 14(3):221-5; discussion 225-6. PubMed ID: 15933322
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality and productivity assessment of clinical pharmacy interventions.
    Baciewicz AM; Cowan RI; Michaels PE; Kyllonen KS
    Hosp Formul; 1994 Nov; 29(11):773, 777-9. PubMed ID: 10138574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjusting dosage intervals of intermittent intravenous ranitidine according to creatinine clearance: a cost-minimization analysis.
    Connelly JF
    Hosp Pharm; 1994 Nov; 29(11):992, 996-8, 1001. PubMed ID: 10138581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of intravenous ranitidine to oral therapy.
    Baciewicz AM
    DICP; 1991 Mar; 25(3):251-2. PubMed ID: 2028631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of intravenous H2-receptor antagonists in a tertiary care hospital.
    Dettmer RM; Riley TH; Byfield F; Green PH
    Am J Gastroenterol; 1999 Dec; 94(12):3473-7. PubMed ID: 10606306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of oral communication on intravenous wastage: talk is cheap.
    Boomer G; Savoy LB; Marten R
    Hosp Pharm; 1993 May; 28(5):404-5, 407-9. PubMed ID: 10126024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Criteria-based antimicrobial i.v. to oral conversion program.
    Okpara AU; Maswoswe JJ; Stewart K
    Formulary; 1995 Jun; 30(6):343-8. PubMed ID: 10144873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary quality assessment of a unit dose drug distribution system.
    Hoffmann RP; Bartt KH; Berlin L; Frank BM
    Hosp Pharm; 1984 Mar; 19(3):167-9, 173-4. PubMed ID: 10265846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency drug therapy for a healthier bottom line.
    Jorgenson J
    Healthc Inform; 1993 Jun; 10(6):22-4, 26. PubMed ID: 10126965
    [No Abstract]   [Full Text] [Related]  

  • 15. A retrospective-prospective study of medication errors: basis for an ongoing monitoring program.
    Hall KW; Ebbeling P; Brown B; Shwortz I
    Can J Hosp Pharm; 1985 Oct; 38(5):141-3, 146. PubMed ID: 10274427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for reducing i.v. drug waste and coping with increased workload.
    Hoolihan RJ; Erickson BA
    Hosp Pharm; 1987 Sep; 22(9):871-6. PubMed ID: 10312222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A process and considerations for activating a quality/productivity monitoring system.
    Rudnick JD
    Health Care Strateg Manage; 1987 Mar; 5(3):23-7. PubMed ID: 10301587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing i.v. waste to under 2.25 percent.
    Newhouse JG; Paul VM; Waugh NA; Frye CB
    Hosp Pharm; 1988 Mar; 23(3):241-2, 246-7. PubMed ID: 10312459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assurance audit of a system for intermittent intravenous drug administration.
    Davis RL; Raymond GG; Geberbauer CW
    Am J Hosp Pharm; 1992 Feb; 49(2):400-2. PubMed ID: 1554006
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary versus functional medication administration: monitoring and evaluating medication error rates.
    Poster EC; Pelletier L
    J Nurs Qual Assur; 1988 Feb; 2(2):68-76. PubMed ID: 3335596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.